Publication | Open Access

Tumor Regression and Autoimmunity in Patients Treated With Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Interleukin 2: A Phase I/II Study

Tumor ImmunologyInterleukin 2AllergyAutoimmune DiseasePhase I/ii StudyPatients TreatedImmunodeficienciesCancer ImmunosurveillanceImmunologyTumor ImmunityAutoimmunityT Cell ImmunityImmunomodulationCd4 T Cell ResponsesImmunotherapyMedicine